Migraine Management
Series: Handbook of Clinical Neurology; 199;
- Publisher's listprice EUR 240.00
-
101 808 Ft (96 960 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 20 362 Ft off)
- Discounted price 81 446 Ft (77 568 Ft + 5% VAT)
101 808 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier
- Date of Publication 14 March 2024
- ISBN 9780128233573
- Binding Hardback
- No. of pages632 pages
- Size 261x192 mm
- Language English 587
Categories
Long description:
Migraine Management, Volume 199 covers the effective treatment of migraines, including different subtypes of migraines in different patient populations. The classification and diagnostic criteria of common and uncommon subtypes of migraine is explored in detail, including childhood variants. An in-depth analysis of the pharmacology of acute and prophylactic agents is presented, along with an evidence-based review of pharmacologic management. This includes recently developed CGRP monoclonal antibodies and non-peptide small molecule CGRP antagonists. Advances in neuromodulatory treatments, both noninvasive and implantable are also critically reviewed.
Finally, specific treatment-related issues in pregnancy and lactation and childhood as well as the elderly are covered. Issues related to the diagnosis and management of vestibular migraine and the co-morbid disorder of persistent postural-perceptual dizziness are also explored.
Table of Contents:
Section I. Migraine Management
1. Non-specific analgesics, combination analgesics, and antiemetics
2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans
3. 5-HT1F agonists
4. CGRP receptor antagonists (Gepants)
5. Preventive treatment of migraine: Non-specific oral agents
6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment
7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention
8. Nutraceuticals in migraine
9. Interventional treatments
10. Biobehavioral treatments of migraine
11. Physical treatment of migraine
12. Neuromodulation in migraine
Section II. Guidelines
13. Evidence-based symptomatic treatment of migraine
14. Evidence-based preventive treatment of migraine
Section III. Special Cases/Situations
15. Treatment in the emergency department
16. Special considerations in migraine during pregnancy and lactation
17. Special considerations in management of migraine in the elderly
18. Management of medication overuse headache
Section IV. Outcome Measures
19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment
Section V. Diagnosis and Treatment of Other Migraine Subtypes
20. Menstrually associated migraine
21. Hemiplegic migraine
22. Migraine with brainstem aura
23. Retinal migraine
24. Vestibular migraine and persistent postural perceptual dizziness
25. Status migrainosus
26. Persistent aura, visual snow, and other visual symptoms
27. Migrainous infarction
28. Migraine in children and adolescents: Assessment and diagnosis
29. Management of migraine in children and adolescents
Section VI. Comorbidities of Migraine
30. Psychiatric comorbidities of migraine
31. Relationship of migraine and other forms of chronic pain
32. Comorbidities of migraine: Sleep disorders
33. The evolving concept of multimorbidity and migraine
Section VII. Future Directions
34. Healthcare disparities faced by patients with migraine and potential mitigation strategies
35. Emerging and future directions of migraine research and treatment
Migraine Management
Subcribe now and receive a favourable price.
Subscribe
101 808 HUF
